professional guideline
American Urological Association
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026)
Published May 7, 2026 · Last checked August 14, 2026
Evidence library
Read the sources behind the treatment model.
Primary professional guidelines, FDA records, and selected longer-term clinical studies. A source’s inclusion does not mean every claim from that source is adopted without qualification.
Evidence reviewed August 14, 2026Clinical review pending; evidence sources are shown
Open
prospective trial follow-up
BJUI Compass
WATER versus WATER II 5-year update: Aquablation in 30–80 and 80–150 mL prostates
Published September 9, 2024 · Last checked August 14, 2026
randomized trial follow-up
Canadian Journal of Urology
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study
Published June 1, 2017 · Last checked August 14, 2026
prospective cohort follow-up
Canadian Urological Association Journal
Long-term outcomes after treatment with Optilume BPH: Four-year results from EVEREST
Published November 1, 2024 · Last checked August 14, 2026
professional guideline
European Association of Urology
Diagnostic Evaluation — Management of Non-neurogenic Male LUTS
Published March 1, 2026 · Last checked August 14, 2026
professional guideline
European Association of Urology
Disease Management — Management of Non-neurogenic Male LUTS
Published March 1, 2026 · Last checked August 14, 2026
randomized trial follow-up
European Urology Focus
Prostatic artery embolisation versus TURP: 5-year outcomes of a randomised trial
Published September 1, 2024 · Last checked August 14, 2026
professional guideline
The Journal of Urology
AUA Guideline (2026) Part I: Presentation and Evaluation
Published May 7, 2026 · Last checked August 14, 2026
professional guideline
The Journal of Urology
AUA Guideline (2026) Part II: Medical Management
Published May 7, 2026 · Last checked August 14, 2026
professional guideline
The Journal of Urology
AUA Guideline (2026) Part III: Procedural/Surgical Management
Published May 7, 2026 · Last checked August 14, 2026
randomized trial follow-up
The Journal of Urology
Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of Water Vapor Thermal Therapy
Published September 1, 2021 · Last checked August 14, 2026
regulatory record
U.S. Food and Drug Administration
AQUABEAM Robotic System — 510(k) K231024
Published August 30, 2023 · Last checked August 14, 2026
regulatory record
U.S. Food and Drug Administration
iTind System — 510(k) K210138
Published June 25, 2021 · Last checked August 14, 2026
regulatory record
U.S. Food and Drug Administration
Optilume BPH Catheter System — PMA P220029
Published June 30, 2023 · Last checked August 14, 2026
regulatory record
U.S. Food and Drug Administration
ProVee System for BPH — PMA P250011
Published December 9, 2025 · Last checked August 14, 2026
regulatory record
U.S. Food and Drug Administration
Rezum System — 510(k) K250584
Published June 11, 2025 · Last checked August 14, 2026
regulatory record
U.S. Food and Drug Administration
UroLift Advanced Tissue Control System — 510(k) K200441
Published June 5, 2020 · Last checked August 14, 2026
regulatory record
U.S. Food and Drug Administration
Zenflow Spring Implant and Delivery System — PMA P250007
Published December 11, 2025 · Last checked August 14, 2026
randomized trial
Urology
The iTind Temporarily Implanted Nitinol Device: A Multicenter Randomized Controlled Trial
Published July 1, 2021 · Last checked August 14, 2026